Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What Causes Hypertrophic Cardiomyopathy?
Bradley A. Maron, Rui‐Sheng Wang, Mercedes R. Carnethon, et al.
The American Journal of Cardiology (2022) Vol. 179, pp. 74-82
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases
Rui‐Sheng Wang, Bradley A. Maron, Joseph Loscalzo
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 4, pp. 493-503
Open Access | Times Cited: 36
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy
Jiří Bonaventura, Ethan J. Rowin, Raymond H. Chan, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
Maja Schlittler, Peter P. Pramstaller, Alessandra Rossini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14845-14845
Open Access | Times Cited: 21
Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy
Jingxuan Guo, Huanzhu Jiang, David Schuftan, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109954-109954
Open Access | Times Cited: 4
Prevalence, Patient Characteristics, and Treatment of Patients with Hypertrophic Cardiomyopathy: A Nationwide Payer Database Study
Yuika Ikeda, Tsunehisa Yamamoto, Makio Torigoe, et al.
Cardiology and Therapy (2025)
Open Access
Model‐Informed Recommendation of Mavacamten Posology for Chinese Adults With Obstructive Hypertrophic Cardiomyopathy
Xiaojie Wu, Shilpa Puli, Nanye Chen, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Yasushi Imai, Kengo Kusano, Takeshi Aiba, et al.
Journal of Cardiology (2025) Vol. 85, Iss. 2, pp. 115-176
Open Access
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Patryk Skórka, Jakub Piotrowski, Estera Bakinowska, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction
Edward Burford, Yande Kasolo, Jane Draper, et al.
Open Heart (2025) Vol. 12, Iss. 1, pp. e003218-e003218
Open Access
GADD45A suppression contributes to cardiac remodeling by promoting inflammation, fibrosis and hypertrophy
Xavier Palomer, Manuel Vázquez‐Carrera, Javier Pizarro‐Delgado, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Genetic Insights from Consanguineous Cardiomyopathy Families
Constance Maurer, Olga Boleti, Paria Najarzadeh Torbati, et al.
Genes (2023) Vol. 14, Iss. 1, pp. 182-182
Open Access | Times Cited: 10
Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis
Maria Pisklova, German Osmak
International Journal of Cardiology (2024) Vol. 410, pp. 132220-132220
Closed Access | Times Cited: 3
Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
Jiří Bonaventura, Ethan J. Rowin, Martin S. Maron, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 7
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes
Xiaojie Wu, Nanye Chen, Peiwen Hsu, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 2
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease
Yasushi Imai, Kengo Kusano, Takeshi Aiba, et al.
Circulation Journal (2024)
Open Access | Times Cited: 2
Characterization of heterozygous and homozygous mouse models with the most common hypertrophic cardiomyopathy mutation MYBPC3 in the Netherlands
Sarah Hilderink, Maike Schuldt, Max Goebel, et al.
Journal of Molecular and Cellular Cardiology (2023) Vol. 185, pp. 65-76
Open Access | Times Cited: 4
Inverse Association between Exercising Blood Pressure Response and Left Ventricular Chamber Size and Mass in Women Who Habitually Resistance Train
Evan L. Matthews, John J. Guers, Meghan G. Ramick, et al.
Healthcare (2024) Vol. 12, Iss. 3, pp. 353-353
Open Access | Times Cited: 1
A meta-analysis approach to gene regulatory network inference identifies key regulators of cardiovascular diseases
Gerardo Pepe, R Appierdo, Gabriele Ausiello, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Transcriptomics data integration and analysis to uncover hallmark genes in hypertrophic cardiomyopathy
Peng Chen
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 637-653
Open Access | Times Cited: 1
A Meta-Analysis Approach to Gene Regulatory Network Inference Identifies Key Regulators of Cardiovascular Diseases
Gerardo Pepe, R Appierdo, Gabriele Ausiello, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4224-4224
Open Access | Times Cited: 1
The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum
Srinjay Mukhopadhyay, Prithvi Dixit, Najiyah Khanom, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 17, Iss. 5, pp. 1119-1139
Open Access | Times Cited: 1
Necroptosis and immune infiltration in hypertrophic cardiomyopathy: novel insights from bioinformatics analyses
Can Hou, Sifan Fei, Fang Jia
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Considerations for drug trials in hypertrophic cardiomyopathy
J. Farrant, Matthias Schmitt, Anna Reid, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 1
Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms
Mila Glavaški, Andrej Preveden, Djordje G. Jakovljević, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1566-1566
Open Access | Times Cited: 6
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy
Nicolas Verheyen, Johannes Auer, Nikolaos Bonaros, et al.
Wiener klinische Wochenschrift (2024) Vol. 136, Iss. S15, pp. 571-597
Open Access
Page 1 - Next Page

Scroll to top